These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 28821581

  • 21. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
    Soma L, Cornfield DB, Prager D, Nowell P, Bagg A.
    Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
    [Abstract] [Full Text] [Related]

  • 22. Expression of S100 Protein in CD4-positive T-cell Lymphomas Is Often Associated With T-cell Prolymphocytic Leukemia.
    Aggarwal N, Pongpruttipan T, Patel S, Bayerl MG, Alkan S, Nathwani B, Surti U, Kitahara S, Chinthammitr Y, Swerdlow SH.
    Am J Surg Pathol; 2015 Dec; 39(12):1679-87. PubMed ID: 26379148
    [Abstract] [Full Text] [Related]

  • 23. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
    Magro CM, Morrison CD, Heerema N, Porcu P, Sroa N, Deng AC.
    J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
    [Abstract] [Full Text] [Related]

  • 24. "T-cell prolymphocytic leukemia (T-PLL), a heterogeneous disease exemplified by two cases and the important role of cytogenetics: a multidisciplinary approach".
    Tirado CA, Starshak P, Delgado P, Rao N.
    Exp Hematol Oncol; 2012 Aug 20; 1(1):21. PubMed ID: 23211026
    [Abstract] [Full Text] [Related]

  • 25. TCL1 is overexpressed in patients affected by adult T-cell leukemias.
    Narducci MG, Stoppacciaro A, Imada K, Uchiyama T, Virgilio L, Lazzeri C, Croce CM, Russo G.
    Cancer Res; 1997 Dec 15; 57(24):5452-6. PubMed ID: 9407948
    [Abstract] [Full Text] [Related]

  • 26. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Kawamoto K, Miyoshi H, Yanagida E, Yoshida N, Kiyasu J, Kozai Y, Morikita T, Kato T, Suzushima H, Tamura S, Muta T, Kato K, Eto T, Seki R, Nagafuji K, Sone H, Takizawa J, Seto M, Ohshima K.
    Eur J Haematol; 2017 May 15; 98(5):459-466. PubMed ID: 28129454
    [Abstract] [Full Text] [Related]

  • 27. Deregulated expression of TCL1 causes T cell leukemia in mice.
    Virgilio L, Lazzeri C, Bichi R, Nibu K, Narducci MG, Russo G, Rothstein JL, Croce CM.
    Proc Natl Acad Sci U S A; 1998 Mar 31; 95(7):3885-9. PubMed ID: 9520462
    [Abstract] [Full Text] [Related]

  • 28. T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis.
    Fang H, Beird HC, Wang SA, Ibrahim AF, Tang Z, Tang G, You MJ, Hu S, Xu J, Li S, Yin CC, El Hussein S, Le N, Futreal PA, Bueso-Ramos C, Thakral B, Kadia TM, Thornton R, Little L, Gumbs C, Song X, Medeiros LJ, Wang W.
    Leukemia; 2023 Sep 31; 37(9):1919-1921. PubMed ID: 37443196
    [No Abstract] [Full Text] [Related]

  • 29. Application of cross-species color banding (RxFISH) in the study of T-prolymphocytic leukemia.
    Espinet B, Solé F, Salido M, Lloveras E, Abella E, Besses C, Serrano S, Woessner S, Florensa L.
    Haematologica; 2000 Jun 31; 85(6):607-12. PubMed ID: 10870117
    [Abstract] [Full Text] [Related]

  • 30. Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia.
    Bergmann AK, Schneppenheim S, Seifert M, Betts MJ, Haake A, Lopez C, Maria Murga Penas E, Vater I, Jayne S, Dyer MJ, Schrappe M, Dührsen U, Ammerpohl O, Russell RB, Küppers R, Dürig J, Siebert R.
    Genes Chromosomes Cancer; 2014 Apr 31; 53(4):309-16. PubMed ID: 24446122
    [Abstract] [Full Text] [Related]

  • 31. Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family-negative T-prolymphocytic leukemia.
    Fang H, Wang SA, Beird HC, Tang Z, You MJ, Li S, Xu J, Hu S, Yin CC, El Hussein S, Lin P, Jelloul FZ, Vega F, Medeiros LJ, Wang W.
    Am J Clin Pathol; 2024 Jun 30. PubMed ID: 38946194
    [Abstract] [Full Text] [Related]

  • 32. Expression of TCL1 in hematologic disorders.
    Roos J, Hennig I, Schwaller J, Zbären J, Dummer R, Burg G, Tobler A, Virgilio L, Croce CM, Fey MF, Borisch B.
    Pathobiology; 2001 Jun 30; 69(2):59-66. PubMed ID: 11752899
    [Abstract] [Full Text] [Related]

  • 33. B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia.
    Ruchlemer R, Parry-Jones N, Brito-Babapulle V, Attolico I, Wotherspoon AC, Matutes E, Catovsky D.
    Br J Haematol; 2004 May 30; 125(3):330-6. PubMed ID: 15086413
    [Abstract] [Full Text] [Related]

  • 34. Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.
    Thick J, Metcalfe JA, Mak YF, Beatty D, Minegishi M, Dyer MJ, Lucas G, Taylor AM.
    Oncogene; 1996 Jan 18; 12(2):379-86. PubMed ID: 8570215
    [Abstract] [Full Text] [Related]

  • 35. Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia.
    Rose A, Zhang L, Jain AG, Poovathukaran Babu A, Sokol L, Saeed H, Mo Q, Fan W, Zhang X.
    Am J Hematol; 2023 Jun 18; 98(6):913-921. PubMed ID: 36964941
    [Abstract] [Full Text] [Related]

  • 36. Integration of conventional cytogenetics, comparative genomic hybridisation and interphase fluorescence in situ hybridisation for the detection of genomic rearrangements in acute leukaemia.
    McGrattan P, Campbell S, Cuthbert R, Jones FG, McMullin MF, Humphreys M.
    J Clin Pathol; 2008 Aug 18; 61(8):903-8. PubMed ID: 18474541
    [Abstract] [Full Text] [Related]

  • 37. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia.
    Han Y, Xue Y, Zhang J, Wu Y, Pan J, Wang Y, Shen J, Dai H, Bai S.
    Cancer Genet Cytogenet; 2008 Dec 18; 187(2):125-9. PubMed ID: 19027493
    [Abstract] [Full Text] [Related]

  • 38. Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition.
    Bug S, Dürig J, Oyen F, Klein-Hitpass L, Martin-Subero JI, Harder L, Baudis M, Arnold N, Kordes U, Dührsen U, Schneppenheim R, Siebert R.
    Cancer Genet Cytogenet; 2009 Jul 18; 192(1):44-7. PubMed ID: 19480937
    [Abstract] [Full Text] [Related]

  • 39. Conventional karyotyping and fluorescence in situ hybridization: an effective utilization strategy in diagnostic adult acute myeloid leukemia.
    He R, Wiktor AE, Hanson CA, Ketterling RP, Kurtin PJ, Van Dyke DL, Litzow MR, Howard MT, Reichard KK.
    Am J Clin Pathol; 2015 Jun 18; 143(6):873-8. PubMed ID: 25972330
    [Abstract] [Full Text] [Related]

  • 40. Aberrations of MYC are a common event in B-cell prolymphocytic leukemia.
    Flatley E, Chen AI, Zhao X, Jaffe ES, Dunlap JB, Pittaluga S, Abdullah S, Olson SB, Spurgeon SE, Fan G.
    Am J Clin Pathol; 2014 Sep 18; 142(3):347-54. PubMed ID: 25125625
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.